Mirum Pharmaceuticals Inc

-0.05 (-0.21%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)881.19M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$23.58 Million
Adjusted EPS-$1.01
See more estimates
10-Day MA$23.44
50-Day MA$20.20
200-Day MA$22.19
See more pivots

Mirum Pharmaceuticals Inc Stock, NASDAQ:MIRM

950 Tower Lane, Suite 1050, Foster City, California 94404
United States of America
Phone: +1.650.667.4085
Number of Employees: 137


Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.